Volker Gudziol1, Thomas Hummel. 1. Smell & Taste Clinic, Department of Otorhinolaryngology, University of Dresden Medical School, Dresden, Germany.
Abstract
OBJECTIVE: To investigate the effect of pentoxifylline, an unspecific phosphodiesterase inhibitor, on olfactory function. DESIGN: Longitudinal study. PATIENTS: Nineteen patients who received pentoxifylline to treat inner-ear conditions. MAIN OUTCOME MEASURES: Evaluation of olfactory function (ie, odor threshold, odor discrimination, and odor identification) before and after administration of pentoxifylline and assessment of nasal airflow. RESULTS: Administration of pentoxifylline had no significant effect on nasal airflow (P = .84). After administration of pentoxifylline, patients demonstrated a decrease in odor threshold toward lower odor concentrations (P = .01). The odor threshold shift after administration of pentoxifylline was more pronounced in younger patients than in older patients (correlation between age and change in odor threshold: r = -.72; P = .001). No such changes were observed for suprathreshold olfactory tasks (odor discrimination and odor identification). Six of the 19 patients were found to have hyposmia. Two patients demonstrated a clinically significant decrease in odor threshold after drug administration. CONCLUSIONS: The present findings may indicate a role for pentoxifylline in the treatment of olfactory loss. Double-blind, placebo-controlled studies are needed to verify whether pentoxifylline can improve olfactory sensitivity in patients with olfactory disorders.
OBJECTIVE: To investigate the effect of pentoxifylline, an unspecific phosphodiesterase inhibitor, on olfactory function. DESIGN: Longitudinal study. PATIENTS: Nineteen patients who received pentoxifylline to treat inner-ear conditions. MAIN OUTCOME MEASURES: Evaluation of olfactory function (ie, odor threshold, odor discrimination, and odor identification) before and after administration of pentoxifylline and assessment of nasal airflow. RESULTS: Administration of pentoxifylline had no significant effect on nasal airflow (P = .84). After administration of pentoxifylline, patients demonstrated a decrease in odor threshold toward lower odor concentrations (P = .01). The odor threshold shift after administration of pentoxifylline was more pronounced in younger patients than in older patients (correlation between age and change in odor threshold: r = -.72; P = .001). No such changes were observed for suprathreshold olfactory tasks (odor discrimination and odor identification). Six of the 19 patients were found to have hyposmia. Two patients demonstrated a clinically significant decrease in odor threshold after drug administration. CONCLUSIONS: The present findings may indicate a role for pentoxifylline in the treatment of olfactory loss. Double-blind, placebo-controlled studies are needed to verify whether pentoxifylline can improve olfactory sensitivity in patients with olfactory disorders.
Authors: Abdulrahman K Ahmed; Reem Sayad; Islam A Mahmoud; Aya M Abd El-Monem; Salma H Badry; Islam H Ibrahim; Mahmoud Hr Hafez; Mohamed A El-Mokhtar; Ibrahim M Sayed Journal: J Neurovirol Date: 2022-03-05 Impact factor: 2.643
Authors: Heike Rebholz; Ralf J Braun; Dennis Ladage; Wolfgang Knoll; Christoph Kleber; Achim W Hassel Journal: Front Neurol Date: 2020-10-26 Impact factor: 4.003